OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy
Sjoerd Nota, David O. Osei-Hwedieh, David L. Drum, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Sjoerd Nota, David O. Osei-Hwedieh, David L. Drum, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Showing 5 citing articles:
Chondrosarcoma: New Molecular Insights, Challenges in Near-Patient Preclinical Modeling, and Therapeutic Approaches
Lorena Landuzzi, Francesca Ruzzi, Pier‐Luigi Lollini, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1542-1542
Open Access | Times Cited: 1
Lorena Landuzzi, Francesca Ruzzi, Pier‐Luigi Lollini, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1542-1542
Open Access | Times Cited: 1
Role of immunotherapy in chondrosarcoma: A case report and review of the literature
Adam Cohen‐Nowak, Danielle B. Dressler, Adam Rock, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 11
Adam Cohen‐Nowak, Danielle B. Dressler, Adam Rock, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 11
Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma
Vincenzo Ingangi, Annarosaria De Chiara, Gerardo Ferrara, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 977-977
Open Access | Times Cited: 4
Vincenzo Ingangi, Annarosaria De Chiara, Gerardo Ferrara, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 977-977
Open Access | Times Cited: 4
Chondroitin sulfate proteoglycan 4: An attractive target for antibody-based immunotherapy
Tomohiro Kurokawa, Kohzoh IMAI
Proceedings of the Japan Academy Series B (2024) Vol. 100, Iss. 5, pp. 293-308
Open Access | Times Cited: 2
Tomohiro Kurokawa, Kohzoh IMAI
Proceedings of the Japan Academy Series B (2024) Vol. 100, Iss. 5, pp. 293-308
Open Access | Times Cited: 2
Chondroitin sulfate proteoglycan 4 (CSPG4) increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying TGFβ signaling
A. Macaulay, Jianbo Yang, Matt A. Price, et al.
British Journal of Dermatology (2024)
Closed Access | Times Cited: 1
A. Macaulay, Jianbo Yang, Matt A. Price, et al.
British Journal of Dermatology (2024)
Closed Access | Times Cited: 1
